1,3-dimethylbarbituric acid

We are 1,3-dimethylbarbituric acid CAS: 769-42-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: 1,3-dimethylbarbituric acid
CAS No: 769-42-6
Synonym: 
1,3-dimethylbarbituric acid
1,3-dimethyl-1,3-diazinane-2,4,6-trione
1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione
 
Density 1.3±0.1 g/cm3
Boiling Point 228.1±23.0 °C at 760 mmHg
Melting Point 121-123 °C(lit.)
Molecular Formula C6H8N2O3
Molecular Weight 156.139
Flash Point 95.3±15.0 °C
Exact Mass 156.053497
PSA 57.69000
LogP -2.21
Vapour Pressure 0.1±0.5 mmHg at 25°C
Index of Refraction 1.511
 
Specification
Appearance: White to cream crystalline powder
Assay(HPLC) ≥99.0% 
Assay by titration ≥98.0% 
Water ≤0.5% 
Melting point 119-126oC 
Loss on drying ≤0.50%
Sulphated ash ≤0.20% 
Solubility Solution in methanol should be clear
 
Application:
1,3-dimethylbarbituric acid is mainly used as oseltamivir intermediates for the prevention of plague bird flu drug
 
Package: 25kgs/drum
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

1,3-dimethylbarbituric acid


Related News: The iLet Bionic Pancreas System is a pocket-sized, wearable investigational medical device that is designed to autonomously control blood-sugar levels.6775-78-6 Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.6,6-dimetilhept-1-en-4-yn-3-ol CAS:78629-20-6 Characteristic APIs are usually more complex in structure, and their synthesis involves a variety of technologies such as chiral synthesis, green synthesis, and catalysis, which requires high research and development capabilities in the production process of API companies.2,6-diaminopiridina CAS:141-86-6 The Company’s first-of-kind approach involves engineering human iPSCs in a one-time genetic modification event and selecting a single engineered iPSC for maintenance as a clonal master iPSC line.Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.

Related Products
Product Name
9,9-dimethyl-10-phenyl-9,10-dihydroacridine View Details
5-Norbornene-2,3-Dicarboxylic Anhydride View Details
4-Amino-1-methylpiperidine View Details
2,2-diethoxy-N-methylethanamine manufacturer 3-(9-phenyl-carbazol-3-yl)-9H-carbazole manufacturer (3S,4S)-3-Hexyl-4-[(2S)-2-hydroxytridecyl]-2-oxetanone manufacturer 2-bromobenzo[b]-naphtho[2,3-d]furan manufacturer N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine manufacturer